INSTYLLA
Instylla’s focus is to leverage hydrogel technology .
INSTYLLA
Industry:
Biotechnology Commercial Medical Device
Founded:
2017-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.instylla.com
Total Employee:
11+
Status:
Active
Total Funding:
33.48 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
Ascension Ventures
Ascension Ventures investment in Series B - Instylla
Sparta Group
Sparta Group investment in Series B - Instylla
Incept BioSystems
Incept BioSystems investment in Series B - Instylla
AMED Ventures
AMED Ventures investment in Series B - Instylla
Catalyst Health Ventures
Catalyst Health Ventures investment in Series B - Instylla
Excelestar Ventures
Excelestar Ventures investment in Series B - Instylla
Official Site Inspections
http://www.instylla.com
- Host name: 221.65.215.35.bc.googleusercontent.com
- IP address: 35.215.65.221
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Instylla"
About - Instylla
Instylla is a company that develops liquid embolics for interventional oncology and peripheral hemostasis. Its first product, Embrace™ Hydrogel Embolic System, is designed for controlled, …See details»
Instylla - Crunchbase Company Profile & Funding
Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology. It is a Bedford, Massachusetts-based company. independently held firm with the major objective of developing next …See details»
Instylla Company Profile 2024: Valuation, Funding & Investors
Instylla General Information Description. Developer of liquid embolic intended for interventional radiology. The company's offering is designed for controlled, complete, and persistent …See details»
Instylla - LinkedIn
Instylla is focused on developing next-generation liquid embolics for interventional radiology, with initial clinical applications in interventional oncology and peripheral hemostasis.See details»
Instylla - Funding, Financials, Valuation & Investors - Crunchbase
Instylla is a medical equipment supplier that provides liquid embolics of the next generation for interventional radiology. Search Crunchbase. ... How much funding has this organization …See details»
INSTYLLA INC. Company Profile | Bedford, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for INSTYLLA INC. of Bedford, MA. Get the latest business insights from Dun & Bradstreet.See details»
Instylla Company Profile - Office Locations, Competitors ... - Craft
Instylla $33.5 m in total funding,. See insights on Instylla including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Instylla, Inc. | Our Companies | Ascension Ventures
Instylla is a development-stage company creating a new standard in embolization therapy for use in interventional radiology and oncology that will allow physicians to perform a variety of …See details»
Leadership Archives - Instylla
Aug 31, 2023 Ben Bell has over 20 years of experience in product design, development, commercialization, and manufacturing of medical devices. He has worked for Boston …See details»
Instylla - VentureRadar
" Instylla is a privately held company based in Bedford, MA, focused on developing next-generation liquid embolics for interventional radiology, with initial clinical applications in …See details»
Instylla - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Instylla . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Senior Clinical Field Manager Stephanie …See details»
Instylla Announces Completion of $30MM EQUITY Financing
Aug 22, 2023 Secured financing advances Instylla’s clinical trials and commercialization readiness BEDFORD, Mass., – August 15, 2023 – Instylla, Inc.See details»
Instylla, Inc. (Instylla, Inc.) - 药物管线_专利_临床试验_投融营收
Clinical investigators achieve significant milestone by enrolling 150 patients with hypervascular tumors in pivotal randomized study. BEDFORD, Mass., May 14, 2024 /PRNewswire/ -- …See details»
Instylla Announces Completion of $30MM EQUITY Financing
Aug 15, 2023 Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the closing of a $30 million financing …See details»
Series B - Instylla - 2020-10-14 - Crunchbase
Oct 14, 2020 Organization Name . Instylla . Announced Date Oct 14, 2020; Funding Type Series B; Funding Stage Early Stage Venture; Money Raised . $25.4M. Lead Investors. Edit Lead …See details»
Instylla Inc. | Catalyst Health Ventures
Oct 14, 2020 Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models. August 1, 2022; Instylla Announces Enrollment of …See details»
Press Releases - Instylla
May 14, 2024 Instylla was named the Emerging #MedTech Company of the Year, while Conformal Medicine was named Powerhouse MedTech Company of the Year. Reply on …See details»
Instylla Completes Enrollment of Landmark Hypervascular Tumor …
May 14, 2024 The Instylla HES Hypervascular Tumor Pivotal Study is a prospective, multicenter, randomized clinical study to evaluate the safety and effectiveness of Instylla's Embrace™ …See details»
Instylla: An Easy, Predictable, and Simpler Way to Embolize Tumors
Instylla Inc., founded in 2017, is addressing interventional oncology with a hydrogel-based liquid for tumor embolization, a therapy that shrinks tumors by blocking their blood supply. Instylla …See details»